Amrutanjan Health Care gets ESG rating of 60 from CRISIL

General View source PDF Explain this filing

AMRUTANJAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.4%Reaction day

₹504.70

prior close

₹508.25

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+1.2% vs market

Pharmaceuticals peers, median of 168sector-0.2%+1.6% vs sector

On the reaction day the stock moved 1.2 pts more than Nifty Microcap 250 and 1.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

-0.0

15m

-0.0

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.4+0.3+1.2-0.2+1.6

Next day

+0.1+1.1-1.1-0.3+0.4

+0.3+1.3-1.0-0.4+0.7

-0.1+2.0-2.2-0.7+0.6

+0.4+0.3+0.0-1.2+1.6

+2.4+1.1+1.4-1.0+3.4

-2.1-3.2+1.1-4.2+2.1

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Amrutanjan Health Care Limited has been assigned an ESG score of 60 by CRISIL ESG Ratings and Analytics, placing it in the Adequate category. CRISIL conducted this assessment voluntarily and independently, without being engaged by the company, based on public disclosures and information available in the public domain.

Likely market impact

ESG rating disclosure may attract sustainability-focused investors; Adequate category rating indicates room for improvement in ESG practices.